Takashi Ohno1, Kohsuke Kudo2, Greg Zaharchuk3, Noriyuki Fujima4, Hiroki Shirato1. 1. Department of Radiation Medicine, Hokkaido University Graduate School of Medicine, Sapporo, Japan. 2. Department of Diagnostic and Interventional Radiology, Hokkaido University Hospital, N14 W5 Kita-ku, Sapporo, 060-8648, Japan. kkudo@huhp.hokudai.ac.jp. 3. Department of Radiology, Stanford University, Stanford, CA, USA. 4. Department of Diagnostic and Interventional Radiology, Hokkaido University Hospital, N14 W5 Kita-ku, Sapporo, 060-8648, Japan.
Abstract
PURPOSE: The purpose of the present study was to determine optimal threshold of vascular pixel elimination (VPE) for CT perfusion (CTP) and to assess diagnostic accuracy of CTP by comparing with xenon enhanced CT (XeCT) in moyamoya disease. MATERIALS AND METHODS: Twenty-three patients underwent XeCT and CTP. Cerebral blood flow (CBF) images were generated for XeCT and CTP using nine types of software. Region of interest (ROI) measurement was performed on XeCT-CBF and CTP-CBF. Linear regression analysis was performed between XeCT-CBF and CTP-CBF in all software, without and with VPE. The Pearson correlation coefficient was calculated, and an optimal threshold was determined based on maximum correlation coefficients. Correlation coefficients at various VPE thresholds including data of no-VPE were compared with each other. The maximum correlation coefficient at the optimal threshold was also compared. RESULTS: Optimal thresholds varied among software types (0.8-2.2 and 7-14 ml/100 g in relative and absolute VPE, respectively). There were significant differences between correlation coefficients at a range of VPE thresholds compared to no-VPE in most software types. There were significant differences in maximum correlation coefficient at optimal threshold among various software types. CONCLUSION: Optimal threshold of VPE for CTP could be determined and diagnostic accuracy of CTP varied among software types in moyamoya disease.
PURPOSE: The purpose of the present study was to determine optimal threshold of vascular pixel elimination (VPE) for CT perfusion (CTP) and to assess diagnostic accuracy of CTP by comparing with xenon enhanced CT (XeCT) in moyamoya disease. MATERIALS AND METHODS: Twenty-three patients underwent XeCT and CTP. Cerebral blood flow (CBF) images were generated for XeCT and CTP using nine types of software. Region of interest (ROI) measurement was performed on XeCT-CBF and CTP-CBF. Linear regression analysis was performed between XeCT-CBF and CTP-CBF in all software, without and with VPE. The Pearson correlation coefficient was calculated, and an optimal threshold was determined based on maximum correlation coefficients. Correlation coefficients at various VPE thresholds including data of no-VPE were compared with each other. The maximum correlation coefficient at the optimal threshold was also compared. RESULTS: Optimal thresholds varied among software types (0.8-2.2 and 7-14 ml/100 g in relative and absolute VPE, respectively). There were significant differences between correlation coefficients at a range of VPE thresholds compared to no-VPE in most software types. There were significant differences in maximum correlation coefficient at optimal threshold among various software types. CONCLUSION: Optimal threshold of VPE for CTP could be determined and diagnostic accuracy of CTP varied among software types in moyamoya disease.
Authors: Max Wintermark; Musa Sesay; Emmanuel Barbier; Katalin Borbély; William P Dillon; James D Eastwood; Thomas C Glenn; Cécile B Grandin; Salvador Pedraza; Jean-François Soustiel; Tadashi Nariai; Greg Zaharchuk; Jean-Marie Caillé; Vincent Dousset; Howard Yonas Journal: Stroke Date: 2005-08-11 Impact factor: 7.914
Authors: Max Wintermark; Gregory W Albers; Andrei V Alexandrov; Jeffry R Alger; Roland Bammer; Jean-Claude Baron; Stephen Davis; Bart M Demaerschalk; Colin P Derdeyn; Geoffrey A Donnan; James D Eastwood; Jochen B Fiebach; Marc Fisher; Karen L Furie; Gregory V Goldmakher; Werner Hacke; Chelsea S Kidwell; Stephan P Kloska; Martin Köhrmann; Walter Koroshetz; Ting-Yim Lee; Kennedy R Lees; Michael H Lev; David S Liebeskind; Leif Ostergaard; William J Powers; James Provenzale; Peter Schellinger; Robert Silbergleit; Alma Gregory Sorensen; Joanna Wardlaw; Ona Wu; Steven Warach Journal: Stroke Date: 2008-04-10 Impact factor: 7.914
Authors: M Pham; A Johnson; A J Bartsch; C Lindner; W Müllges; K Roosen; L Solymosi; M Bendszus Journal: Neurology Date: 2007-08-21 Impact factor: 9.910